abstract |
A more effective anti-HCV treatment is provided. The present invention relates to compositions and co-crystals each comprising VX-950 and a co-crystal former selected from the group consisting of salicylic acid, 4-aminosalicylic acid and oxalic acid. Moreover, the manufacturing method and the usage method are also within the scope of the present invention. [Selection figure] None |